Drakenterprises

Not clinical advice. Clinical Evidence is a current-awareness feed. It is not a clinical decision-support system, not medical advice, and not a substitute for clinical judgment, institutional protocols, or the original sources. Full text, NCCN recommendations, and Cochrane review bodies are not reproduced here.

Home · otolaryngology

Oto-HNSArticle

Five Year Recovery From COVID-19 Smell Loss: Preliminary Report from a Nationwide Survey.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · AAO-HNS · 09/01/2026

Authors: Tucker, Aaron; Reiter, Evan R; Costanzo, Richard M; Coelho, Daniel H

Publication types: Journal Article

PubMed abstract / permitted excerpt

This scientific briefing reports preliminary 5-year recovery outcomes from COVID-19-associated smell loss in a nationwide cohort. Adults with confirmed COVID-19 infection and self-reported smell loss since January 2020 were surveyed through a longitudinal web-based questionnaire, and a follow-up survey was distributed to participants who had completed a prior 2-year study. Among 419 respondents (mean age 45.7 ± 13.7 years; 79.0% female; 84.5% white), 44.2% reported complete smell recovery, 48.4% partial recovery, and 7.4% no recovery or worsening smell. Complete recovery was significantly higher in participants younger than 40 years (P < .001) but did not differ by gender (P = .51). Compared with 2-year outcomes, the rate of complete recovery increased from 38.4% to 44.3%. These findings indicate that while modest additional recovery occurs beyond 2 years, olfactory dysfunction persists in more than half of patients 5 years after COVID-19-associated smell loss. While a much larger analysis is currently in progress, this report represents the longest-term results published to date.

Full-text bodies are not stored. AAO-HNS CPG hub is outbound. Journal via PubMed.

Clinical Evidence